| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
6,020 |
5,239 |
$810K |
| J0178 |
Injection, aflibercept, 1 mg |
1,795 |
1,186 |
$746K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
730 |
445 |
$505K |
| 92134 |
|
5,612 |
4,975 |
$72K |
| 92250 |
|
1,172 |
1,065 |
$46K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
117 |
77 |
$40K |
| J9035 |
Injection, bevacizumab, 10 mg |
801 |
568 |
$30K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
340 |
314 |
$12K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
41 |
37 |
$2K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
98 |
86 |
$942.68 |
| J3590 |
Unclassified biologics |
30 |
25 |
$13.29 |